Overview
Ingibjorg Jonsdottir practices practicing medicine in Goeteborg, Sweden.
Their clinical expertise encompasses COVID-19, Obsessive-Compulsive Disorder (OCD), and Severe Acute Respiratory Syndrome (SARS).
They are actively involved in clinical research, co-authoring 82 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Ingibjorg H. Jonsdottir
Is Ingibjorg H. Jonsdottir a top-rated expert for COVID-19?
MediFind is an objective health platform that identifies experts based on real-world data. Ingibjorg H. Jonsdottir is classified as an Experienced expert for COVID-19, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Ingibjorg H. Jonsdottir participate in research or clinical trials?
Yes. Ingibjorg H. Jonsdottir has published 82 articles and abstracts on conditions like COVID-19. You can view a list of Ingibjorg H. Jonsdottir's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- COVID-19Jonsdottir isExperienced. Learn about COVID-19.
- Obsessive-Compulsive Disorder (OCD)Jonsdottir isExperienced. Learn about Obsessive-Compulsive Disorder (OCD).
- Severe Acute Respiratory Syndrome (SARS)